Identification of E-Box Factor TFE3 as a Functional Partner for the E2F3 Transcription Factor

REFERENCES

• Babb, R., C. C. Huang, D. J. Aufiero, and W. Herr. 2001. DNA recognition by the herpes simplex virus transactivator VP16: a novel DNA-binding structure. Mol. Cell. Biol. 21: 4700–4712.
   PubMedGoogle Scholar
• Bates, S., A. C. Phillips, P. A. Clark, F. Stott, G. Peters, R. L. Ludwig, and K. H. Vousden. 1998. p14ARF links the tumour suppressors RB and p53. Nature 395: 124–125.
   PubMed Web of Science ®Google Scholar
• Brodin, G., A. Hgren, C.-H. Dijke, and R. Heuchel. 2000. Efficient TGF-β induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter. J. Biol. Chem. 275: 29023–29030.
   PubMed Web of Science ®Google Scholar
• Cartwright, P., H. Muller, C. Wagener, K. Holm, and K. Helin. 1998. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 17: 611–623.
   PubMedGoogle Scholar
• Dahl, R., B. Wani, and M. J. Hayman. 1998. The Ski oncoprotein interacts with Skip, the human homolog of Drosophila Bx42. Oncogene 26: 1579–1586.
   Google Scholar
• DeGregori, J., G. Leone, A. Miron, L. Jakoi, and J. R. Nevins. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94: 7245–7250.
   PubMed Web of Science ®Google Scholar
• Dynlacht, B. D., K. Moberg, J. A. Lees, E. Harlow, and L. Zhu. 1997. Specific regulation of E2F family members by cyclin-dependent kinases. Mol. Cell. Biol. 17: 3867–3875.
   PubMed Web of Science ®Google Scholar
• Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12: 2245–2262.
   PubMed Web of Science ®Google Scholar
• Fry, C. J., A. Pearson, E. Malinowski, S. M. Bartley, J. Greenblatt, and P. J. Farnham. 1999. Activation of the murine dihydrofolate reductase promoter by E2F1. J. Biol. Chem. 274: 15883–15891.
   PubMed Web of Science ®Google Scholar
• Gaubatz, S., J. G. Wood, and D. M. Livingston. 1998. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc. Natl. Acad. Sci. USA 95: 9190–9195.
   PubMedGoogle Scholar
• Giangrande, P. H., E. A. Kimbrel, D. P. Edwards, and D. P. McDonnel. 2000. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol. Cell. Biol. 20: 3102–3115.
   PubMed Web of Science ®Google Scholar
• Hardy, S., D. A. Engel, and T. Shenk. 1989. An adenovirus early region 4 gene product is required for induction of the infection-specific form of cellular E2F activity. Genes Dev. 3: 1062–1074.
   PubMedGoogle Scholar
• Hardy, S., and T. Shenk. 1989. E2F from adenovirus-infected cells binds cooperatively to DNA containing two properly oriented and spaced recognition sites. Mol. Cell. Biol. 9: 4495–4506.
   PubMedGoogle Scholar
• Heimann, P., H. El Housni, G. Ogur, M. A. Weterman, E. M. Petty, and G. Vassart. 2001. Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17) (p11.2;q25.3)-bearing papillary renal cell carcinomas. Cancer Res. 61: 4130–4135.
   PubMedGoogle Scholar
• Hua, X., X. Liu, D. O. Ansari, and H. F. Lodish. 1998. Synergistic cooperation of TFE3 and Smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev. 12: 3084–3095.
   PubMed Web of Science ®Google Scholar
• Hua, X., Z. A. Miller, H. Benchabane, J. L. Wrana, and H. F. Lodish. 2000. Synergism between transcription factors TFE3 and Smad3 in transforming growth factor β-induced transcription of the Smad7 gene. J. Biol. Chem. 275: 33205–33208.
   PubMed Web of Science ®Google Scholar
• Hua, X., Z. A. Miller, G. Wu, Y. Shi, and H. F. Lodish. 1997. Specificity in transforming growth factor β-induced transcription of the plasminogen activator inhibitor-1 gene: Interactions of promoter DNA, transcription factor mE3, and Smad proteins. Proc. Natl. Acad. Sci. USA 96: 13130–13135.
   Google Scholar
• Humbert, P. O., R. Verona, J. M. Trimarchi, C. Rogers, S. Dandapani, and J. A. Lees. 2000. E2f3 is critical for normal cellular proliferation. Genes Dev. 14: 690–703.
   PubMed Web of Science ®Google Scholar
• Jacquemin, P., J. A. Martial, and I. Davidson. 1997. Human TEF-5 is prentially expressed in placenta and binds to multiple functional elements of the human chorionic somatomammotropin-β enhancer. J. Biol. Chem. 272: 12928–12937.
   PubMedGoogle Scholar
• Jost, C. A., D. Ginsbreg, and W. G. Kaelin, Jr. 1996. A conserved region of unknown function participates in the recognition of E2F family members by the adenovirus E4 ORF 6/7 protein. Virology 220: 78–90.
   PubMedGoogle Scholar
• Kowalik, T. F., J. DeGregori, J. K. Schwarz, and J. R. Nevins. 1995. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69: 2491–2500.
   PubMedGoogle Scholar
• Krek, W., M. E. Ewen, S. Shirodkar, Z. Arany, W. G. Kaelin, and D. M. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78: 161–172.
   PubMed Web of Science ®Google Scholar
• Krek, W., G. Xu, and D. M. Livingston. 1995. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83: 1149–1158.
   PubMed Web of Science ®Google Scholar
• Lees, J. A., M. Saito, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13: 7813–7825.
   PubMed Web of Science ®Google Scholar
• Leone, G., J. DeGregori, Z. Yan, L. Jakoi, S. Ishida, R. S. Williams, and J. R. Nevins. 1998. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12: 2120–2130.
   PubMed Web of Science ®Google Scholar
• Leone, G., R. Sears, E. Huang, R. Rempel, F. Nuckolls, C.-H. Park, P. Giangrande, L. Wu, H. Saavedra, S. J. Field, M. A. Thompson, H. Yang, Y. Fujiwara, M. E. Greenberg, S. Orkin, C. Smith, and J. R. Nevins. 2001. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol. Cell 8: 105–113.
   PubMedGoogle Scholar
• Lin, W.-C., F.-T. Lin, and J. R. Nevins. 2001. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15: 1833–1845.
   PubMed Web of Science ®Google Scholar
• Macchi, P., L. Notarangelo, S. Giliani, D. Strina, M. Repetto, M. G. Sacco, P. Vezzoni, and A. Villa. 1995. The genomic organization of the human transcription factor 3 (TFE3) gene. Genomics 28: 491–494.
   PubMedGoogle Scholar
• Marti, A., C. Wirbelauer, M. Scheffner, and W. Krek. 1999. Interaction between SCFSKP2 ubiquitin protein ligase and E2F-1 underlies regulation of E2F-1 degradation. Nat. Cell Biol. 1: 14–19.
   PubMed Web of Science ®Google Scholar
• Moroni, M. C., E. S. Hickman, E. L. Denchi, G. Caprara, E. Colli, F. Cecconi, H. Muller, and K. Helin. 2001. Apaf-1 is a transcriptional target for E2F and p53. Nat. Cell Biol. 3: 552–558.
   PubMed Web of Science ®Google Scholar
• Morris, L., K. E. Allen, and N. B. La Thangue. 2000. Regulation of E2F transcription by cyclin E-cdk2 kinase mediated through p300/CBP co-activators. Nat. Cell Biol. 2: 232–239.
   PubMed Web of Science ®Google Scholar
• Neill, S. D., C. Hemstrom, A. Virtanen, and J. R. Nevins. 1990. An adenovirus E4 gene product trans-activates E2 transcription and stimulates stable E2F binding through a direct association with E2F. Proc. Natl. Acad. Sci. USA 87: 2008–2012.
   PubMedGoogle Scholar
• Neill, S. D., and J. R. Nevins. 1991. Genetic analysis of the adenovirus E4 6/7 transactivator: interaction with E2F and induction of a stable DNA-protein complex are critical for activity. J. Virol. 65: 5364–5373.
   PubMedGoogle Scholar
• Nevins, J. R. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9: 585–593.
   PubMedGoogle Scholar
• Nishikawa, N. S., M. Izuni, H. Uchida, M. Yokoi, H. Miyazawa, and F. Hanaoka. 2000. Cloning and characterization of the 5′-upstream sequence governing the cell cycle-dependent transcription of mouse DNA polymerase α 68 kDa subunit gene. Nucleic Acids Res. 28: 1525–1534.
   PubMedGoogle Scholar
• O'Connor, R. J., and P. Hearing. 1994. Mutually exclusive interaction of the adenovirus E4-6/7 protein and the retinoblastoma gene product with internal domains of E2F-1 and DP-1. J. Virol. 68: 6848–6862.
   PubMedGoogle Scholar
• Ogawa, H., K. Ishiguro, S. Gaubatz, D. M. Livingston, and Y. Nakatani. 2002. A complex with chromatin modifiers that occupies E2F and Myc responsive genes in G0. Science 296: 1132–1136.
   PubMed Web of Science ®Google Scholar
• Peers, B., S. Sharma, T. Johnson, M. Kamps, and M. Montminy. 1995. The pancreatic islet factor STF-1 binds cooperatively with Pbx to a regulatory element in the somatostatin promoter: importance of the FPWMK motif and of the homeodomain. Mol. Cell. Biol. 15: 7091–7097.
   PubMed Web of Science ®Google Scholar
• Qin, X.-Q., D. M. Livingston, W. G. Kaelin, and P. D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91: 10918–10922.
   PubMed Web of Science ®Google Scholar
• Raychaudhuri, P., S. Bagchi, S. D. Neill, and J. R. Nevins. 1990. Activation of the E2F transcription factor in adenovirus-infected cells involves E1A-dependent stimulation of DNA-binding activity and induction of cooperative binding mediated by an E4 gene product. J. Virol. 64: 2702–2710.
   PubMedGoogle Scholar
• Schlisio, S., T. Halperin, M. Vidal, and J. R. Nevins. 2002. Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function. EMBO J. 21: 5775–5786.
   PubMedGoogle Scholar
• Seol, W., H. S. Choi, and D. D. Moore. 1995. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol. Endocrinol. 9: 72–85.
   PubMed Web of Science ®Google Scholar
• Shan, B., and W.-H. Lee. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14: 8166–8173.
   PubMedGoogle Scholar
• Sikorski, R. S., and P. A. Hieter. 1989. System of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122: 19–27.
   PubMed Web of Science ®Google Scholar
• Skalsky, Y. M., P. M. Ajuh, C. Parker, A. I. Lamond, G. Goodwin, and C. S. Cooper. 2001. PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors. Oncogene 20: 178–187.
   PubMed Web of Science ®Google Scholar
• Takahashi, Y., J. B. Rayman, and B. D. Dynlacht. 2000. Analysis of promoter binding by the E2F and Rb families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev. 14: 804–816.
   PubMed Web of Science ®Google Scholar
• Trimarchi, J. M., B. Fairchild, R. Verona, K. Moberg, N. Andon, and J. A. Lees. 1998. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA 95: 2850–2855.
   PubMed Web of Science ®Google Scholar
• Trimarchi, J. M., B. Fairchild, J. Wen, and J. A. Lees. 2001. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc. Natl. Acad. Sci. USA 98: 1519–1524.
   PubMedGoogle Scholar
• Trouche, D., and T. Kouzarides. 1996. E2F1 and E1A12S have homologous activation domains regulated by Rb and CBP. Proc. Natl. Acad. Sci. USA 93: 1439–1442.
   PubMedGoogle Scholar
• Weterman, M. A., M. Wilbrink, and A. Geurts van Kessel. 1996. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1) (p11;q21)-positive papillary renal cell carcinomas. Proc. Natl. Acad. Sci. USA 93: 15294–15298.
   PubMed Web of Science ®Google Scholar
• Wu, X., and A. J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91: 3602–3606.
   PubMed Web of Science ®Google Scholar
• Xu, B., J. M. English, J. L. Wilsbacher, S. Stippec, E. J. Goldsmith, and M. H. Cobb. 2000. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J. Biol. Chem. 275: 16795–16801.
   PubMed Web of Science ®Google Scholar
• Xu, M., K.-A. Sheppard, C.-Y. Peng, A. S. Yee, and H. Piwnica-Worms. 1994. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol. 14: 8420–8431.
   PubMed Web of Science ®Google Scholar
• Yamamoto, K. R., B. D. Darimont, R. L. Wagner, and J. A. Iniguez-Lluhi. 1998. Building transcriptional regulatory complexes: signals and surfaces. Cold Spring Harb. Symp. Quant. Biol. 63: 587–598.
   PubMedGoogle Scholar
• Zheng, L., L. Yu, Q. Tu, M. Zhang, H. He, W. Chen, J. Gao, J. Yu, Q. Wu, and S. Zhao. 2000. Cloning and mapping of human PKIB and PKIG, a comparison of tissue expression patterns of three members of the protein kinase inhibitor family, including PKIA. Biochemistry 349: 403–407.
   Google Scholar
• Zheng, N., E. Fraenkel, C. O. Pabo, and N. P. Pavletich. 1999. Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP. Genes Dev. 13: 666–674.
   PubMed Web of Science ®Google Scholar